Efficacy of Unani Polyherbal Formulation in the Management of Chronic Tension Type Headache

Efficacy of Munzij wa Mushil-i-safra and Saut with Roghan-i-kaddu in Usabah (Chronic Tension Type Headache)-A Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079475

Enrollment

Registered

2025-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

Intervention1: Munzij wa Mushil-i-safra and Sa’ut with Roghan-i-Kaddu: Patients of Test Group will be given Munzij-i-Safra for initial 10 days and Mushil-i-Safra will be added with the former on 5th

decoction will be prepared and given to drink in the morning before breakfast for purgation of morbid material. APPLICATION OF ROGHAN-I-KADDU: Patient will be instilled 2-3 drop of roghan-i kaddu

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients from 18 to 65 years of age 2. Patients of all gender 3. Patients conforming to ICHD3 diagnostic criteria of CTTH 4. Intensity of headache score on VAS equal or more than 3 5. Agree to participate in this study and provide written informed consent

Exclusion criteria

Exclusion criteria: 1.Headache caused by other medical disorders (e.g. Known case of subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, head injury, hypertension, migraine, headache due to ophthalmic cause) 2. Patients having any serious co-morbidity involving liver, kidney, cardiovascular, endocrinal and metabolic disorders etc. 3. Pregnant or lactating women 4. Known case of nasal block (polyps, DNS, Turbinate hypertrophy) 5. External injury to nose 6. Patients with pace maker and metallic implant 7. Known case of epilepsy 8. Patients not willing to follow the protocol.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale for intensity of headache (VAS)Timepoint: 0-14-28 day	—

Secondary

Measure	Time frame
Headache Impact Test (HIT)Timepoint: 0-14-28 day	—

Countries

India

Contacts

Public ContactProf Abdul Nasir Ansari

National Institute of Unani Medicine

abdulnasiransari@gmail.com9379165162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026